EUCLIDEAN CAPITAL LLC – RAPT Therapeutics, Inc. Transaction History
EUCLIDEAN CAPITAL LLC portfolio value:
$10.41M
portfolio value
EUCLIDEAN CAPITAL LLC quarter portfolio value change:
+31.84%
quarter
RAPT Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | 2.51M | $24.06 | 432.9K | |
| Q2 2022 | share | 0.00% | 0 shares | -1.61M | $18.25 | 432.9K | |
| Q1 2022 | share | 0.00% | 0 shares | -6.38M | $21.99 | 432.9K | |
| Q4 2021 | share | Decrease | -31.85% | -202.27K shares | -3.82M | $36.28 | 432.9K |
| Q3 2021 | share | Decrease | -13.68% | -100.62K shares | -3.66M | $31.05 | 635.17K |
| Q2 2021 | share | 0.00% | 0 shares | 7.05M | $31.79 | 735.80K | |
| Q1 2021 | share | 0.00% | 0 shares | 1.80M | $22.2 | 735.80K | |
| Q4 2020 | share | Increase | 0.00% | 735.80K shares | 14.53M | $19.75 | 735.80K |